Balanced news tone
News Sentiment
OXB sentiment intelligence
Oxford Biomedica plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
15 relevant articles
News tone and price action are not far from neutral.
93/100 classification confidence.
directly relevant articles
high-authority source matches
-1.3% over one week, +1.8% over four weeks, trend inactive, and materially above fair value.
REG - Oxford Biomedica PLC M&G PLC - Holding(s) in Company
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
93/100 classification
One-week reaction
-1.3%
Price digesting
Trend fit
Trend inactive
1.8% over four weeks
Fair value
48.3%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
13
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingView
Direct company coverage
REG - Oxford Biomedica PLC M&G PLC - Holding(s) in Company
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 13:45
- Source
- TradingView
TradingView
Direct company coverage
REG - Oxford Biomedica PLC - Admission to Trading
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- TradingView
TradingView
Direct company coverage
REG - Oxford Biomedica PLC - Admission to trading application
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- TradingView
Financial Times
Direct company coverage
Oxford BioMedica leaves door open to private equity takeover
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Financial Times
Market source
Direct company coverage
How Oxford Biomedica (LSE:OXB) Is Reframing Its Long Term Value Story Around £8.43
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Market source
Investors' Chronicle
Direct company coverage
Oxford Bio expects solid revenue growth
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 26 Mar 2026 07:00
- Source
- Investors' Chronicle
Reuters
Direct company coverage
EQT backs out of takeover bid for UK's Oxford Biomedica
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Feb 2026 08:00
- Source
- Reuters
Proactive Investors
Direct company coverage
Oxford Biomedica trading update ignored as bid deadline looms
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Proactive Investors
simplywall.st
Direct company coverage
Oxford Innotech Berhad's (KLSE:OXB) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- simplywall.st
Financial Times
Direct company coverage
EQT in talks to take over Oxford BioMedica
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jan 2026 08:00
- Source
- Financial Times
Global Banking & Finance Review
Direct company coverage
EQT Funds Make Unsolicited Offer for Oxford Biomedica Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jan 2026 08:00
- Source
- Global Banking & Finance Review
simplywall.st
Direct company coverage
Revenues Working Against Oxford Biomedica plc's (LON:OXB) Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Dec 2025 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Oxford Biomedica plc (LON:OXB): Is Breakeven Near?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Oct 2025 07:00
- Source
- simplywall.st
Investors' Chronicle
Direct company coverage
Oxford Biomedica ramps up production
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Sep 2025 07:00
- Source
- Investors' Chronicle
White & Case LLP
Direct company coverage
White & Case advises on Oxford Biomedica equity placing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Aug 2025 07:00
- Source
- White & Case LLP